touchPODCAST

touchIN CONVERSATION for touchONCOLOGY

Listen to Ms Nikolina Dodlek, an oncology nurse from Croatia, in conversation with Professor Sherko Kümmel, a leading medical oncologist from Germany. They respond to questions submitted by the HCP audience and provide their expert insights on the use of HER2-directed antibody–drug conjugates (ADCs) in the treatment of patients with breast cancer.

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Daiichi Sankyo Europe GmbH and AstraZeneca. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchoncologyime.org/knowledge-for-nurses-adc-updates-in-breast-cancer

touchPANEL DISCUSSION for touchONCOLOGY 

Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing. 

The experts

• Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.

For further information visit: https://touchoncologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma 

touchPANEL DISCUSSION for touchHAEMATOLOGY

Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing. 

The experts

• Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.

For further information visit: https://touchhaematologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma

touchIN CONVERSATION for touchRESPIRATORY

Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. 

The experts

• Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: 

https://touchrespiratoryime.org/her2_nsclc_testing_and_targeted_therapies/

touchIN CONVERSATION for touchONCOLOGY

Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. 

The experts

• Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: 

https://touchoncologyime.org/her2_nsclc_testing_and_targeted_therapies/

touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights

Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.

The experts:

• Prof. John Chen - Mayo Clinic, Rochester, MN, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurologyime.org/nmosd_diagnosis_treatment

touchIN CONVERSATION for touchOPTHAMOLOGY

Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.

The experts:

• Prof. John Chen - Mayo Clinic, Rochester, MN, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchophthalmologyime.org/nmosd_diagnosis_treatment

touchMDT for touchHAEMATOLOGY

Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.

touchMDT for touchHAEMATOLOGY

Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH.

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME

touchMDT for touchHAEMATOLOGY

Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. 

The multidisciplinary team

• HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA

This touchPODCAST is for healthcare professionals in the USA only.

This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.